Celltrion Takes Big Step On Xolair Biosimilar Journey

Phase I Trial For Omalizumab Candidate Began Last Year

 
• By Dean Rudge
Growth
Celltrion has secured safety data from the interim results of Phase I clinical trials • Source: Shutterstock

More from Products

More from Generics Bulletin